Hylomorph to receive additional R&D funding from the Eurostars/Eureka program
Hylomorph is proud to announce it ranked 2nd out of 283 applications in the competitive Eurostars/Eureka grant. Eurostars is a prestigious grant awarded by the European Commission to support international innovative R&D performing SMEs (Small Medium Enterprises). This additional funding will allow Hylomorph to boost its new device R&D program over the next two years.
Hylomorph obtains Innosuisse certification
Hylomorph is proud to announce that the company has been awarded the Innosuisse certificate, awarded to Swiss start-up companies that have demonstrated readiness for sustainable growth. Simone Bottan, Hylomorph's CEO, said "Innosuisse has been fundamental in guiding Hylomorph out of academia into a commercial venture. It has trained, coached, stimulated, and challenged us, as part of an unmatched program in the Swiss economic ecosystem."
Hylomorph Secures 3.2MCHF Series A-Round led by Fongit Seed Invest (FSI)
Press release can be found here.
A micron-scale surface topography design reducing cell adhesion to implanted materials
If you are interested in the science behind our technology, please check out our recent publication showing how the combination of microtopography and a highly biocompatible surface can reduce cell adhesion to a minimum.